Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lizzia Raffaghello

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Clinical Neuropathology|July 20, 2021
Muscle inflammatory pattern in alpha- and gamma-sarcoglycanopathiesChiara Panicucci, Serena Baratto, Lizzia Raffaghello, et al.
Cancer Immunology, Immunotherapy : CII|June 11, 2011
Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patientsFabio Morandi, Maria Valeria Corrias, Isabella Levreri, et al.
Plos One|December 31, 2009
CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytesAnna Corcione, Elisa Ferretti, Maria Bertolotto, et al.
Scientific Reports|November 5, 2025
Anti-tumor efficacy and Vδ2 T-cell activation via EGFR antibody-drug conjugates featuring novel aminobisphosphonatesDoretta Cuffaro, Linda Di Gregorio, Camilla Mangini, et al.
Free Radical Biology & Medicine|November 10, 2007
Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastomaBarbara Marengo, Chiara De Ciucis, Daniela Verzola, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
P2X7 Receptor Antagonist Reduces Fibrosis and Inflammation in a Mouse Model of Alpha-Sarcoglycan Muscular DystrophyLizzia Raffaghello, Elisa Principi, Serena Baratto, et al.
Neuropediatrics|May 31, 2023
Early Muscle MRI Findings in a Pediatric Case of Emery-Dreifuss Muscular Dystrophy Type 1Chiara Panicucci, Sara Casalini, Monica Traverso, et al.
Oncoimmunology|January 4, 2018
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical modelPaola Bocca, Emma Di Carlo, Ignazio Caruana, et al.
Brain & Development|February 16, 2023
Long-term clinical and MRI follow-up in two POMT2-related limb girdle muscular dystrophy (LGMDR14) patientsChiara Panicucci, Sara Casalini, Beatrice M Damasio, et al.
Science Translational Medicine|February 11, 2012
Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapyChanghan Lee, Lizzia Raffaghello, Sebastian Brandhorst, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Clinical Neuropathology|July 20, 2021
Muscle inflammatory pattern in alpha- and gamma-sarcoglycanopathiesChiara Panicucci, Serena Baratto, Lizzia Raffaghello, et al.
Cancer Immunology, Immunotherapy : CII|June 11, 2011
Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patientsFabio Morandi, Maria Valeria Corrias, Isabella Levreri, et al.
Plos One|December 31, 2009
CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytesAnna Corcione, Elisa Ferretti, Maria Bertolotto, et al.
Scientific Reports|November 5, 2025
Anti-tumor efficacy and Vδ2 T-cell activation via EGFR antibody-drug conjugates featuring novel aminobisphosphonatesDoretta Cuffaro, Linda Di Gregorio, Camilla Mangini, et al.
Free Radical Biology & Medicine|November 10, 2007
Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastomaBarbara Marengo, Chiara De Ciucis, Daniela Verzola, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
P2X7 Receptor Antagonist Reduces Fibrosis and Inflammation in a Mouse Model of Alpha-Sarcoglycan Muscular DystrophyLizzia Raffaghello, Elisa Principi, Serena Baratto, et al.
Neuropediatrics|May 31, 2023
Early Muscle MRI Findings in a Pediatric Case of Emery-Dreifuss Muscular Dystrophy Type 1Chiara Panicucci, Sara Casalini, Monica Traverso, et al.
Oncoimmunology|January 4, 2018
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical modelPaola Bocca, Emma Di Carlo, Ignazio Caruana, et al.
Brain & Development|February 16, 2023
Long-term clinical and MRI follow-up in two POMT2-related limb girdle muscular dystrophy (LGMDR14) patientsChiara Panicucci, Sara Casalini, Beatrice M Damasio, et al.
Science Translational Medicine|February 11, 2012
Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapyChanghan Lee, Lizzia Raffaghello, Sebastian Brandhorst, et al.
Pageof 9